A teen with Duchenne reports improvement on Solid’s gene therapy, and investors take notice – STAT
STAT |
A teen with Duchenne reports improvement on Solid’s gene therapy, and investors take notice
STAT 14-year-old boy with Duchenne muscular dystrophy 1 has regained some strength and function in his muscles following treatment with an experimental gene therapy from Solid Biosciences, the boy’s father tells STAT. And although it’s just a single case … |
News-Medical.net |
Flow of cerebrospinal fluid found to be key signal for neural stem cell renewal
News-Medical.net Stem cells in the brain can divide and mature into neurons participating in various brain functions, including memory. In a paper published in the journal ‘Cell Stem Cell‘, scientists at Helmholtz Zentrum München and Ludwig-Maximilians-Universität … Novel robotic system can grow mini human organsDeccan Herald Stem Cell Cure Offering Safe and Effective Stem Cell Treatments for Muscular DystrophyDigital Journal 2022 Animal Stem Cell Therapy Market: Global Manufacturers Analysis, Revenue, Market Share, Types, ApplicationsExpert Consulting Technical Progress –CryptoNexa all 41 news articles » |
Benzinga |
Uniqure Notches Bullish Initiation On Gene Therapy Prospects
Benzinga Uniqure’s dominant gene therapy platform with an AAVS vector; its potential “best-in-class” lead gene therapy candidate AMT-061 for treating hemophilia B; and pipeline optionality for treating Huntington’s and genetically driven heart disease create a … |
Benzinga |
Uniqure Notches Bullish Initiation On Gene Therapy Prospects
Benzinga Uniqure’s dominant gene therapy platform with an AAVS vector; its potential “best-in-class” lead gene therapy candidate AMT-061 for treating hemophilia B; and pipeline optionality for treating Huntington’s and genetically driven heart disease create a … |